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1 Introduction
While fetal monitoring by means of sonography
and cardiotocography has now been fully estab-
lished and accepted, varying opinions still exist
regarding the use of endocrine methods. The
determination of different placental hormones
in an effort to reduce fetal mortality has been
suggested for many years [4, 9, 12, 17, 18, 25,
26]. Even though the necessity of determining
estrogens in serum and/or urine is evident, it
is hardly practiced. Based on the results of a
prospective study on pregnancy control, it is
intended to evaluate several different endocrine
methods with focus on the determination of
estrogens. In future papers, various placental
proteins will be dealt with.
Estriol (Es) amounting to 85% of estrogens
produced during pregnancy is quantitatively
the most important of the estrogens. Up to
90% of Es is formed on the basis of fetal precur-
sors. From this it would appear that conclu-
sions concerning any fetal condition could most
readily be drawn from the determination and
interpretation of Es concentrations in maternal
serum. With regard to this it should be men-
tioned that the reaction of free serum Es is far
more sensitive than that of total serum Es [11,
13, 22].
Ninety percent of the estrogens to be found
in excreted maternal urine are composed of
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glucuronized estriol, which means that the de-
termination of total estrogen excretion in 24
hours also appears to be the most likely para-
meter to be assessed. In a high risk group of
patients a close connection between Es or the
urinary estrogens (UE) and fetal emergency
situations has been demonstrated [9, 12, 24].
It has not been clarified whether or not it is
necessary to carry out screening examinations
in all pregnancies. Furthermore, so far no study
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has been carried out to prove whether a connec- Twelve to 24 months after birth, questionnaires
tion between the estrogen concentration and concerning the development of the children
early infants' development can be established. were sent to the individual parents. Complete
_ . . r Λ r tl ,. information regarding cause of and responseThree issues arise from he following investiga- to treatment ̂  ^ m caseg m which
tion The first concerns the value of E3 and UE .̂̂  had ed medical attention of had
analysis before the 34th week of ̂ station for been h italiz^ The results of lar di_
the screening of clinical abnormalities of he ^nations (8 days, 1, 6, 12, and 24
fetus at birth. The second concerns the value wefe also int ted in the stud A
of serial estrogen measurements after the 34th ' cMdren die(f immediatel following
week of pregnancy and in the last 5 weeks of ^ ̂  of ̂
before delivery to detect fetuses at risk. The * * children were
third concerns the value of estnol measure- .t - - A r ^ *· A * Λ
A ^ „ ι < . · „ . · / - available after one year of observation. At thements to allow a long term prognostication of , r - - ^ i^ r ***ι . ~ ,, * ! a .. end of the second year the results from 661early infant s development. ..... /^0o/\ · -i 1-1 to. rJ ^ children (78%) were available. The group of
the children for whom our data were available
after 1 and 2 years was fully comparable to the
2 Materials and methods group of children who did not show up for
^ . , ,„, ,Λ_Λ lt - , medical follow-up. Due to the increased perina-During the years 1976 to 1979 all of the women ^ mortalit of these children onl the A
who visited the Outpatient Department at the score wag si ificantl lower in the latter
University Women s Hospital for the first time
(before the 20th week of pregnancy) were in- All data relating to pregnancy and delivery as
eluded in a prospective balanced study. Within well as the neonate and the infants' develop-
this study they were examined regularly, and at ment during the first two years of life were
the same time blood samples were taken and computerized at the Heidelberg University
sonographic examinations carried out. During Computer Center. Es was determined from deep
the last trimester, cardiotocograms were taken frozen serum. Free Es was extracted with di-
and the total urinary estrogen output within ethyl ether and measured by radioimmunoassay
24 hours was determined. Clinical management with an antiserum against 6-oxoestriol-carbo-
was in no way influenced by hormone results, methoxine-BSA (intraassay precision was be-
which were determined after delivery. Fetal low 6%, interassay precision was 7%, sensitivi-
wellbeing was demonstrated by ultrasound, ty was 30 pg/ml, cross reactions with various
nonstress and contraction stress tests. steroids were below 2%). UE was measured
In order to obtain relevant data for all the wi^a modified ™β*οα. acc<*d?nf to OSAWA
weeks of pregnancy, the study was balanced. and SLAUN^g1l (mtra- and interassay pre-
Each patient drew a number that made her C1S1°? was 5%>'T*f overall incidence of mad-
eligible to enter one of the four sub-groups of equate Unne collectlon was 5%.
the study. Within these groups, certain pregnan- Due to the fact that a relatively large number of
cy weeks were chosen in which examinations at analyses was available (2846 Es samples taken
the clinic were planned and in which blood during the 28th to 40th week of pregnancy), all
samples were taken. There were absentees in all values were examined up to the time of delivery
groups. A total of 1140 women was included with regard given to the state of health of the
in the study. On account of miscarriages, insuf- individual fetus. Corresponding examinations
ficient examinations and missed appointments, were carried out for UE (1940 samples were
260 patients were eliminated from the study, taken during weeks 28 to 40 of pregnancy). In
Multiple births (n = 11) were not studied, so order to obtain a realistic comparison, only
that the following results of the study are based those samples were taken into consideration
on 869 patients. that had been employed for both methods
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within a period of 3 days. Estrogen drops due
to antibiotic, dexamethasone or bctamimetic
therapy were eliminated before calculation.
When in a given week of pregnancy more than
one result was available, one value was ran-
domly chosen. Evaluation of the estrogen re-
sults was in accordance with the following prin-
ciples:
1. Estrogen concentrations for each indivi-
dual week of pregnancy were measured.
2. During 28th to 34th week of pregnancy
one sample of every patient was chosen at
random to evaluate the screening efficiency.
3. Serial determinations made in the 35th to
40th week of pregnancy. The prevalent con-
centration values were taken into calcula-
tion for each patient.
4. Serial determinations during the last 5
weeks prior to delivery were interpreted as
shown under 3).
Correlations were made with Spearman Corre-
lation Coefficient (SC), Wilcoxon (WT), Krus-
kal-Wallis (KW), and chi square tests (ST). Dif-
ferences with p < 0.05 were considered signifi-
cant.
Sensitivity
Truly positive (TP) χ 100
Truly positive (TP) and false negative (FN)
specificity
Truly negative (TN) χ 100












TP + FP FN + TN
were calculated for various important variables
(Apgar score, growth retardation, intensive
care, "at risk").
Estrogen concentration increases during the
course of pregnancy. It is not possible to com-
pare the absolute concentration of the indivi-
dual week of pregnancy, which is why the estro-
gen level of each week of pregnancy was divided
into percentiles. The normal range was deter-
Figure 1. Normal range of Ej and UE concentrations
during weeks 25 and 41 of pregnancy. Median, 10th and
90th percentiles are given.
mined by 229 women whose singleton pregnan-
cies and deliveries were recorded as uncompli-
cated (as indicated by the following parameters:
delivery at ^ 37 weeks of pregnancy of an
infant > 10th percentile of weight for age and
sex, no fetal distress in labour requiring inter-
vention or admission to special care, Apgar
scores > 8 at 1 minute and > 9 at 5 and
10 minutes, cord artery pH > 7.20. Pregnancy
occured after spontaneous ovulation, no bleed-
ing during pregnancy, no illness recorded dur-
ing pregnancy, no kind of prescription or other
drugs taken during the pregnancy, sonographi-
cal examinations showed a gestalional age of
the individual fetus which corresponded to the
estimated age of pregnancy). Low values were
defined as below the 10th percentile, normal
ones between the 10th and the 90th percentile,
high ones above the 90th percentile. In figure
1 median, 10th and 90th percentiles calculated
on the basis of this method are shown for £3
and UE.
3 Results
The main clinical data relating to pregnancy
and delivery are given in table I. More than
200 variables were checked. Important data
J. Pcrinat. Mcd. 14 (1986)
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Toxemia of pregnancy 26
Delivery < 36th week of pregnancy 10
Postterm pregnancy 2
Delivery by
— Cesarean section (primary) 15 (6)
— vaginally spontaneous 78
— forceps or vacuum 7
SGA 9
Γ Apgar score < 7 12












Sex ratio c?: -φ-







51 ± 3.7 cm
35 ± 1.5cm
51 : 49
Table Π. Clinical data of 759 infants one year and of
661 infants two years after birth.
Variables mean ± SD/%
One year
Sitting 7 ± 1.4mth
Standing 9 ± 1.7mth
Walking 12.8 ± 1.7 mth
Talking > 5 words at age one 61
Neurological sequelae 8
Diseases in the first year 25
Malformations (heart, hip, etc.) 9






Body weight 12.7 ± 1.6 kg
Body height 90 ± 5 cm
Number of teeth 17.6 ± 2.5
Obvious mental retardation 5
Diseases in the second year 60
Hospitalization in the first 2 years 15
Susceptibility for infections 30
Sleep disorders 12
Convulsions 2
Neurological sequelae with two years 3
Seeing and hearing defects ' 1.6
Speech disorders 5
Unsatisfactory control of bowel and
bladder 33
concerning the children's development in the
first and second year are shown in table II.
"Cerebral palsy" included asymmetric muscle
tone, hypotonia or hypertonia with and without
functional disorders. At the age of two years
"neurological sequelae" were only diagnosed in
cases with functional disorders. Children with
major malformations or Down's syndrome
have not been considered in the description of
the 2 years' development.
Statistical analyses of these data revealed that
the infants' development up to two years of
age was significantly influenced by prematurity,
toxemia, cesarean section, low placental weight,
low birth weight, low pH of the cord blood, and
low Apgar scores. Therefore, the correlation of
all the factors mentioned above with maternal
estrogen levels was studied in detail.
3.1 Estriol (E3)
3.1.1 Weekly determination
For each of the weeks 28 to 40 of pregnancy a
close connection between Es, the weight of the
placenta (SC 0.3, ρ < 0.01) and the infants'
weight at birth (SC 0.25, ρ < 0.005) was dem-
onstrated. Only during weeks 28, 30, 32 and 35
to 39 there was a significant correlation to the
J. Perinat. Med. 14 (1986)
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Apgar values (WT p < 0.001). There was no
correlation found with regard to prematurity,
toxemia or pH of the umbilical vein and artery.
3.1.2
cy)
E3 screening (weeks 28—34 of pregnan-
The significant results are compiled in table III,
in which, above all, the infants' weight and
the Apgar score are recorded. There was no
correlation between the infants' sex, the dura-
tion of pregnancy, method of delivery or umbil-
ical vein and artery pH.
Reduced Es concentrations were measured in
11% of the cases, normal ones in 80%, and
increased ones in 9%. The frequency of reduced
Es concentrations was more than double in
Table ΙΠ. Significant correlations between £3 levels
(screening during weeks 28 — 34 of pregnancy) in 869
pregnancies and variables at delivery. SC = Spearman
Correlation Coefficient. KW = Kruskal-Wallis test.





Apgar 1' after birth
Apgar 5' after birth


















Table IV. Estriol screening and birth weight of the new-
born (n = 869). Division of weight percentiles according
to THOMSON [27] into: SGA (< 10th percentile), AGA


























newly born small for gestational age (SGA)
compared to adequate for gestational age
(AGA) infants (table IV).
Mothers of children with a poor Apgar score
1 minute post partum suffered twice as much
from reduced Es concentrations (table V). In
cases in which the Apgar score was still low
after 10 minutes the rate was 3 times higher.
Because of premature births, growth retarda-
tion, low Apgar score and neonatal complica-
tions, 29% of all children in the study had to
be considered to be at risk. The mothers had
almost twice as frequently reduced Es concen-
trations as compared with normal pregnancies.
One third of the newborns with pulmonary
complications were delivered by mothers with
low estriol values. In order to correctly evaluate
the significance of an Es screening, the sensitivi-
ty, specificity, and relative risk are given in table
VI. The specificity was high for all parameters



































Table VI. Diagnostic relevance of estriol screening in
869 pregnancies.
Variable %
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tested. The sensitivity was low, ranging from
17% in detecting infants at risk to 34% in
babies with reduced Apgar scores 10 minutes
after birth.
None of the variables characterizing the infants'
development 1 and 2 years after birth revealed
significant correlations with the Es screening.
However, within the group of newborns with
poor Apgar scores 1 and 10 minutes post par-
turn, it was noticed that the children of mothers
who had reduced Es concentrations had a high-
er illness rate during the first year of their lives,
and their power of speech was deficient at the
end of the first year compared to those of
mothers with normal Es values. Furthermore,
every other child had already been in a hospital
by 2 years, and after normal values it was only
every 9th. With regard to bowel and bladder
control the children with poor Apgar scores
and reduced Es concentrations lagged behind
those children whose mothers had normal Es
concentrations.
3.1.3 E3 serial determinations (weeks 35—41
of pregnancy)
In addition to the Es screening, serial determi-
nations during weeks 35 to 40 were performed
in 423 pregnant women. As can be taken from
table VII, the sensitivity of this method to de-
tect infants at risk increased, whereas the speci-
ficity decreased and the relative risk remained
almost unchanged compared to the Es screen-
ings. If only those children are taken into con-
sideration that needed postnatal intensive care,
Table ΥΠ. Serial Ea determinations (weeks 35-41 of
pregnancy) for detecting infants at risk in 423 pregnan-
cies.
Variable %






























































.10 . . ^-i · »nC« O CO CO 0̂  09 p
α o d co d
ι 55 ι ι °+ ν ο
»ο






m ·̂ so »ο ν^ ίο οο<Ν m »ο -̂ -Η m
O Os <«-! O oo O ^-i^ ̂  r- m <«-i u^ <M








J. Perinat. Med. 14 (1986)
Gerhard et al, Estrogen screening and fetal outcome 285
respiratory distress occurred in a total of 31%
after reduced £3 serial assays and in only 6%
after normal Es levels.
In the first year, children following reduced
Es serial assays showed a significantly higher
incidence of illness (40%) than those following
normal (23%) or increased (15%) Es (WT,
p < 0.01). The percentage of retarded speech
power was higher after low Es values than after
normal or increased Es values (table VIII). At
two years of age, no difference in speech devel-
opment could be found. There was no differ-
ence with respect to sleep patterns. At the end
of the second year, more children had been
ill after reduced Es concentrations than after
normal values, infections of the lung and diges-
tive system being the most frequent diagnoses.
Hospitalization during the first two years of
life appeared to be more frequent after low Es
values; the difference was, however, not signifi-
cant. Though the motor development was inde-
pendent of estriol concentrations, neurological
sequelae with functional handicaps up to two
years of life was most frequent after low Es
levels. The development of bowel and bladder
control following reduced Es serial assays was
slower as compared to pregnancies with normal
and increased Es. There was a significant corre-
lation between the infants' weight at two years
of age and Es concentrations. The parameters
of physical growth did not differ.
3.1.4 £3 serial determinations (last 5 weeks
before delivery)
As the infants' development was strongly influ-
enced by prematurity and Apgar scores, the
role of Es was tested with a view to these
parameters. All premature children with re-
duced Apgar scores and low Es concentrations
were ill at one stage during the first year of
their lives, retarded in speech at the age of one,
and low of weight at the age of two, while the
premature children with low Apgar scores and
normal Es values developed normally. 90% of
the premature children with good Apgar scores
had normal Es concentrations and an uncom-
plicated development up to two years of age.
The disease rate of mature children of mothers
with low Es concentrations was twice as high
during the first year of life (above all pulmonary
disorders and intestinal infections) compared
to those of mothers with normal Es concentra-
tions. The risk of being speech-retarded was
even three times higher. However, no differ-
ences were discovered between the babies of
these groups in respect to muscle tone, move-
ment, reflexes or cranial nerves.
Taking into account the decreasing period of
time between the Es determination and delivery,
the significance of the method increased. So up
to 50% of the SGA could be found and up to
60% of the reduced Apgar scores, provided the
determination was performed in the last 2
weeks before delivery.
3.2 Urinary estrogens (UE)
3.2.1 Weekly determination
Only after the 34th week of gestation was there
a significant connection with the weight percen-
tile for age and sex (KW p < 0.001). The re-




UE-screening (weeks 28—34 of pregnan-
Only a remote connection (ST, p < 0.05) could
be shown between UE on one hand and Apgar
score or percentile of birth weight on the other
Table IX. Diagnostic relevance of urinary estrogen de-
terminations during weeks 28 — 34 of pregnancy in 654
pregnancies.
Variable %
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hand. With regard to this, it was demonstrated
that lower Apgar values and a smaller weight
percentile occurred more frequently after re-
duced UE than after normal or even increased
values. Table IX shows the sensitivity, speci-
ficity, and relative risk of the most important
variables of delivery. The significance was not
as high as it was in the case of the Es determina-
tion. No significant correlation with the devel-
opment of the child in the first two years was
found.
3.2.3 UE serial determinations (weeks 35—41
of pregnancy)
\No significant correlation with the Apgar
scores, the weight percentiles or the remaining
variables could be demonstrated. In table X the
important results of this part of the study are
given. With regard to the development of the
individual children a correlation of reduced UE
to retarded speech, physiotherapy at the age of
two and low body weight at the age of two
could be demonstrated (table VIII).
The correlation coefficient (SC) between Es and
UE varied in the weeks 30 to 40 of pregnancy
from 0.3 to 0.47 (p < 0.0005). With regard to
all examined parameters the importance of the
Es determination was greater than that of UE.
Table X. Serial UE determinations (weeks 35—41 of
pregnancy) for detecting infants at risk in 397 pregnan-
cies.
Variable %






















In the following, only a limited comparison of
our data with the results of other authors is
possible. The definition of so-called normal
range varies greatly. It has to be taken into
account that there is a logarithmic distribution
for hormone concentrations and not a standard
distribution, so that averages and single or
double standard deviations would not be accu-
rate. For this reason, percentiles for the classifi-
cation of hormone levels were chosen. Al-
though, according to this definition, in the nor-
mal group of patients 10% of the hormone
values were decreased, the group of patients
being at risk was expected to be large enough
for statistical analysis.
In other studies, the normal group of patients
is usually not defined as strictly as defined
here, with the complete data variations to the
individual course of pregnancy and birth being
taken into account. Usually, the majority of
studies do not deal with an unselected popula-
tion, but with small groups of patients at risk,
as for instance gestosis or diabetes. Finally,
studies of various other authors cannot be used
for comparison, as these authors determined
total estrogens in serum which does not render
such definite results [8, 9, 11, 17]. In keeping
with numerous other studies [5, 10, 16, 19] our
investigations also showed evidence of retarded
development during the first two years of the
infant's life in cases of premature birth, intra-
uterine growth retardation, low Apgar score
or cesarian section. Due to this, it was here
attempted to find the appropriate method of
determining estriol to allow a correct prognos-
tic evalution of the condition of the infant at
birth and in its early two years development.
For the estriol screening of the study, the 28th
to 34th week of pregnancy were chosen as at
this time there is an increased risk for the un-
born due to intrauterine asphyxia or premature
birth. At the same time the chances of extrau-
terine survival are still limited. During this peri-
od, there was already a significant correlation
between Es concentration and the babies' birth
weight observed, which could not be demon-
strated by UE analysis. It needs to be mention-
ed that the mothers of only 23% of all SGA
children had reduced Es concentrations. It was
possible to improve the sensitivity of the
method through serial determinations of Es,
J. Perinat. Med. 14 (1986)
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the level of which could be used to mark the They calculated a 50-80% sensitivity for this
relationship to growth. 50% of the 1UGR fetus- method. By determination of total £3 in plasma,
es could be diagnosed by Ra one to two weeks EDWARDS ct al [9] could prove a connection
before birth. When interpreting these results, it with Apgar levels, too. This was also true after
must be pointed out that the specificity is less correction of the influence of individual birth
satisfactory in serial determinations, i. e. an in- weight [12].
creasing number of below normal results can The UE excrctjon of tnc patients proved Io
be found in infants with normal weight. havc onjy minor rc|ation to Apgar scores. Even
HARDY et al [15] came to the same conclusion with serial determination the UE were often
as reached here with regard to Ej analysis be- normal whcn E> Wils alrea<Jy bclow norma1· As
yond the 37th week of pregnancy. They obtain- thc «o™ varied so greatly, it must be assumed
ed an even better correlation when the chil- that this was due to inadequate urine collection,
drens' sex, the size of the mother, and the parity although the most obvious mistakes to be made
were taken into consideration. durinß collection were eliminated. By means of
UE excretion method BEISCHUR and BROWN [3]
After the 34th week of pregnancy there was recognized one third of all babies with bad
also evidence of a significant correlation of UE Apgar scores jn 140 cascs of risk pregnancies,
with birthweight, although this could not be AICKIN et al [1] compared the plasma estrogen
demonstrated in serial determinations and was analysis with UE excretion and found that the
also far more inaccurate than was the case with correlation with fetal emergencies was almost
E3. BRISCHBR [4] described the results of UE identical with both methods. Even though the
analysis among 6361 woman in the 32nd and |atter authors could prove a highly significant
the 36th weeks of pregnancy. He observed that correlation between the two levels in 454 re-
lower birth weight was more frequent when the cordecl analyses, they found relevant discrepan-
maternal estnol levels were low (21.7%) than cies between serum and urine estrogens in many
compared to cases with normal estriol levels cases. In some studies a better clinical analysis
(6.6%). wus achieved when serum estrogens in combi-
A significant connection to babies' Apgar nation with urine estrogens were used to predict
scores at birth could be shown for the £3 screen- fetal emergencies. The estrogen/creatinine ratio
ing tests. Lower E.i concentrations were signifi- in earlV morning samples of urine could poss-
cantly correlated to a low Apgar score 10 rnin- tbly improve the UE method [20, 23].
utes after birth. This is understandable since According to the Ej screening and serial deter-
only grave disorders of the newly born cannot niinations, the children of mothers with a low
be compensated in the first 10 minutes post Es level had an increased incidence of neonatal
partum. Depending on the individual period of complications. Thirty two percent of the 19
time elapsed until birth, 60% of the babies with children with respiratory distress syndrome had
low 10 minute Apgar scores could be traced mothers with low hormone levels. The predic-
back to mothers having low Ej concentrations, tive value of U E was less satisfactory. The re-
BASHORB and WBTTLAKB [2] monitored 321 risk maim>no perinatal risk factors for the children's
pregnancies through regular analysis of E3 from development (premature birth, ac.dosis, cesare-
the 32nd week of pregnancy until birth. They »n section) could not be diagnosed through
found that the prognostic value was highest either oi the methods mentioned,
when obtaining blood samples during the last With respect to the infant's development in the
week before birth. If Ej was below 4 ng, which first two years, it was only possible in isolated
is probably comparable with our 5th percentilc, cases to show significant correlations to hor-
therc was a significant correlation to the occur- mone levels determined from blood samples
rence of neonatal problems in all groups who before the 34th week of pregnancy. Considering
were at risk, except for the group with diabetes, the group of children with poor Apgar scores
j. Perinul, Met). 14(1986)
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one minute or 10 minutes after birth, it was of age in babies of lowest birth weights with
striking that with low Ea screening levels the extremely low maternal urinary estrogen.
children proved to have a higher incidence of From ̂  gtud it becomes evident that prog.
illness in their first year, they were more often nogtic statements about the well-bemg of the
in a hospital and were retarded in speech and fetug ftt birth can be obtained more accurately
bowel and bladder control. Serial Es determina- Λ h E3 amu i§ than th h UE analysis
tions in late pregnancy as well as dunng.the whue cages Qf premature birtll cannot be dis.
covered with these methods, iritrauterine
growth retardation and fetal emergencies can
, . , Λ , _ be detected to a certain degree. As the evidenceneurological sequelae up to 2 years because of Qf h retardation is easier to obtain with
functional handicaps and low body weight at ultrasound5 the main importance of E3 analyses
age two. Training of bowel and bladder control ^ ^ ̂  prognosis of possible Apgar scores
appeared to be less efficient in this group. Even at feirth and ead infant,s devel nt. As the
after correction of socio-economic factors these actual gtate Qf ̂  fetug is easu and . n_
last 5 weeks before birth revealed significant
correlations between low Ea levels and illness in
the first 2 years of life, retarded speech power,
Differences remained unchanged The correla- obtained fe nonstress/contraction stress
tion to UE was less significant. With both E3 E3 yalues ̂  usuall not influence dinical
methods no differences were observed with re- ma ent [6]. Even in diabetic tients
gard to the sleep patterns motonc develop- whefe estriol are d ^ de
ment, seeing and hearing abilities. fetal jeopardy [13] ̂  dmical usefulness of Es
To our knowledge the development of children determinations was doubtful [7]. Due to the
in relation to the maternal £3 concentration low sensitivity of the Es method and in view
has not yet been examined. In some previous of cost-benefit-calculations an Es-screening of
studies with 14 or 34 patients, some connection every pregnant woman cannot be recom-
between low UE and psychomotoric develop- mended. In pregnancies at risk, however, serial
ment disorders have been reported [14, 29, 30]. Es determinations once weekly in addition to
TROLLE et al [28] published follow-up studies on ultrasound and nonstress testing allow a better
110 children (8 to 14 years old) with previously prognostication of fetal well-being. In the case
determined level of maternal UE during preg- of reduced Es values maximum postpartum care
nancy. In 27.3% of the cases severe handicaps should be made available for all infants with
were observed after low UE levels had been poor Apgar scoring. The early infants' develop-
registered compared to 1.8% after normal UE ment should be given special attention. Follow-
levels. Speech disorders were found in 12.7% up studies of the children of age four are under
after low UE values compared to 1.8% and way and will include observations of physical
disorders of seeing or hearing in 20% compared growth, intellectual development and neuro-
to 3.6%. Low et al [19] observed a reduced logical assessment in addition to evaluation of
mental and physical development at 12 months vision, hearing and speech.
Summary
In an unselected obstetric population of 869 women
serial determinations of estriol in serum and urine were
performed from the 28th week of pregnancy until deliv-
ery. Clinical management was based on ultrasound and
nonstress/contraction stress tests only. Data on the de-
velopment of the infants were available after 1 year in
759 cases (89%) and after 2 years in 661 cases (78%).
Serum free estriol (Es) screening during weeks 28 — 34
of pregnancy revealed a significantly increased risk for
reduced Apgar scores, growth retardation and postnatal
complications in pregnancies with decreased levels
(p < 0.001). The development of the children was dis-
turbed by a higher incidence of childhood diseases, retar-
dation in speech and bowel and bladder control. The
urinary estrogen determinations (UE) during this period
of pregnancy showed only a vague connection with birth
weight and Apgar scores (p < 0.05) and no connection
to the infant's development. Serial determinations of Es
J. Perinat. Med. 14 (1986)
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after the 35th week of pregnancy increased the signifi-
cance for all parameters tested. If the estrogen concen-
tration was determined in the last 2 weeks before deliv-
ery, 50% of the SGA and 60% of the endangered cases
could be diagnosed. After reduced £3 serial levels neuro-
logical sequelae, reduced body weight, retarded speech
and late development of bowel and bladder control were
significantly more frequent at age two than after normal
Ea levels. The differences obtained by serial UE determi-
nations were less evident. Considering cost-benefit-cal-
culations, an Ea screening of every pregnant woman
cannot recommended. In pregnancies at risk serial Es
determinations allow better prognostication of fetal
well-being. In the case of reduced £3 values maximum
post partum care should be made available for all new-
borns. Special support should be given to the early
infant's development after reduced £3 values have been
observed.
Keywords: Follow-up, maternal estrogen concentrations, perinatal period.
Zusammenfassung
Östrogenbestimmung in der Schwangerschaft: Aussagefa-
higkeit in Bezug auf den kindlichen Zustand bei der
Geburt und die Entwicklung in den ersten zwei Lebens-
jahren
Bei einer Gruppe von 869 nicht selektierten schwangeren
Frauen wurden routinemäßig die Serumöstriolkonzen-
tration (£3) und die Gesamtöstrogenausscheidung im 24
Std.-Harn (UE) von der 28. Schwangerschaftswoche bis
zur Entbindung bestimmt. Die Ergebnisse lagen erst
nach der Geburt vor, so daß sich das klinische Manage-
ment auf den Ultraschall und das CTG (in Ruhe und
ev. nach Oxytocin-Belastung) stützte. Daten über die
kindliche Entwicklung standen nach l Jahr in 759 Fällen
(89%) und nach 2 Jahren in 661 Fällen (78%) zur
Verfügung. Wurden zwischen 28.—34. Schwanger-
schaftswoche erniedrigte Es-Konzentrationen gefunden,
so war das Risiko erniedrigter Apgarwerte, von Wachs-
tumsretardierung und von postnatalen Komplikationen
signifikant erhöht (p < 0,001). Die kindliche Entwick-
lung wurde beeinträchtigt durch eine höhere Inzidenz
von Kinderkrankheiten, Verzögerung der Sprachent-
wicklung und der Sauberkeitserziehung. Während des-
selben Zeitraums wiesen die UE lediglich einen vagen
Schlüsselwörter: Mütterliche Östrogenkonzentrationen, Nachuntersuchung, Neonatalperiode.
Zusammenhang mit dem Geburtsgewicht und den Ap-
gar-Werten (p < 0.05) auf und keinen Zusammenhang
mit der kindlichen Entwicklung. Bei Bestimmungen von
£3 nach der 35. Schwangerschaftswoche erhöhte sich die
Signifikanz bei allen untersuchten Parametern. In den
letzten zwei Wochen vor der Entbindung wiesen 50%
der Mütter mit SGA und 60% der Mütter mit durch
Asphyxie gefährdeten Feten erniedrigte £3 auf. Nach
wiederholt niedrigen E3-Konzentrationen waren im Alter
von 2 Jahren neurologische Probleme, niedriges Körper-
gewicht und eine verzögerte Sprach- und Sauberkeitsent-
wicklung signifikant häufiger als nach normalen £3-
Werten. Die serienmäßige UE-Bestimmung brachte we-
niger deutliche Unterschiede. Im Hinblick auf die Ko-
sten-Nutzen-Relation kann eine Es-Überwachung bei je-
der Schwangeren nicht empfohlen werden, bei Risi-
koschwangerschaften ist damit jedoch eine bessere Pro-
gnostizierung des kindlichen Befindens möglich. Bei nie-
drigen Es-Werten sollte für alle Neugeborenen eine
optimale postnatale Versorgung verfügbar sein. Die
frühkindliche Entwicklung sollte nach niedrigen £3-Wer-
ten besonders gefördert werden.
Resume
Surveillance otstrogenique dans revaluation du devenir
fietal et du developpement infantile
Dans un groupe de 869 femmes enceintes non solec-
tionnees le taux d'cestriol serique (£3) ainsi que Pelimina-
tion des oestrogenes totaux dans les urines de 24 heures
(UE) ont ete doses de fa?on systematique de la 28eme
semaine de gestation jusqu'a 1'accouchement.̂
Les resultats n'etaient disponibles qu'apres Faccouche-
ment, alors que la surveillance clinique etait effectuee
par Pultrasonographie et la cardiotocographie (au repos
et eventuellement apres une charge en oxytocine). Les
donnees sur le developpement infantile etaient disponi-
bles apres un an dans 759 des cas (89%) et apres deux
ans dans 661 des cas (78%).
Si entre la 28eme et la 34eme semaine de gestation les
concentrations d'Es se trouvaient diminuees, le risque
d'un score d'Apgar diminue, d'un retard de croissance
et de complications postnatales etaient augmentes de
fa?on significative (P < 0,001).
Le developpement infantile a ete entrave par une inci-
dence accrue de maladies infantiles, d'un retard de deve-
loppement du langage ainsi que d'un retard dans 1'edu-
cation de la proprete. Pendant ce meine temps les UE
presentaient seulement une relation vaque avec le poids
de naissance et le score d'Apgar (P < 0,05) et aucune
relation avec le developpement infantile. Lors des dosa-
ges d'E3 apres la 3Seme semaine de gestation la significa-
tion de tous les parametres mesures fut augmentee. Pen-
dant les deux dernieres semaines avant accouchement
50% des meres avec SGA et 60% des meres avec foetus
en menace d'asphyxie montraient un £3 diminue. Apres
des dosages repetes de concentrations d'Es diminuees,
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des troubles neurologiques, un retard ponderal et un
developpement du langage et d'education de la proprete
retardes, etaient significativement plus frequents ä Tage
de deux ans qu'apres des valeurs d'Ea normaux. Le
dosage en serie d'UE rapportait moins de differences
evidentes. Au point de vue d'une relation coüt-benefice,
une surveillance d'Es ne peut pas etre recommendee chez
chaque femme enceinte, toutefois, en cas de grossesse ä
risque, cette methode pennet un meilleur pronostic ä
long terme du bien etre infantile.
En cas d'Es abaisse, des soins postnataux optimaux
devraient etre disponible pour tout nouveau-ne. Apres
des valeurs basses d'Ea le developpement de la premiere
enfance devrait etre particulierement encourage.
Mots-cles: Concentration maternelle d'cestrogenes, examen medical postnatal, periode neonatale.
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